A B S T R A C T The transferrin receptor, present on reticulocytes and nucleated cells in tissue culture, has been measured with both immunoassay techniques and transferrin binding studies. The total cellular immunoreactive receptor is rapidly lost from erythrocytes during the process of reticulocyte maturation (from as many as 400,000 molecules to <20,000 molecules/ reticulocyte). This event parallels the loss of cell surface transferrin binding sites and RNA content, and correlates with previous studies that have measured the decline in hemoglobin synthesis.
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Nonhemoglobin-producing normal human fibroblasts, which appear to have a much lower iron requirement than reticulocytes, contain similar numbers of immunoreactive receptors per cell (400,000 receptor molecules), when in an active state of proliferation. Although receptor density on fibroblasts is directly related to cell proliferation, our studies demonstrate that nonproliferating fibroblasts still retain significant numbers of immunoreactive receptors (150,000 molecules/ cell) and transferrin binding sites. Since additional studies indicate that proliferating cells have increased iron uptake, a simple hypothesis would predict that the parallel increase in transferrin binding sites and total cellular immunoreactive receptor associated with proliferation is related to an increased cellular iron requirement. However, the number of immunoreactive receptor molecules and transferrin binding sites is not changed when cells are grown in iron-deficient media, or in media with added transferrin-iron. This result and the lack of marked differences in receptor number on both hemoglobin-producing and nonhemoglobin-producing cells indicate that other factors besides receptor density play major roles in the regulation of cellular iron uptake, retention, and loss. INTRODUCTION Reticulocytes are anucleate, but contain RNA and synthesize a number of different proteins (1) . However, >90% of the protein made in reticulocytes is hemoglobin (1) and studies of human cells have estimated that up to 30% of the hemoglobin found in mature erythrocytes is made at the reticulocyte stage (2) . Cells obtain the iron required for hemoglobin synthesis by a process beginning with the binding of the plasma iron transport protein, transferrin, to specific receptors on the cell surface (3). Previously, transferrin binding studies have indicated that transferrin binding sites are found on cells that synthesize hemoglobin, including reticulocytes, but not on mature erythrocytes (3, 4) . More recently, binding studies performed on multiple samples of reticulocytes obtained from phenylhydrazine-and actinomycin D-treated rabbits have suggested that even before the reticulocyte completely matures (associated with loss of RNA), transferrin binding sites are almost entirely lost from the cell surface (5) . However, whether this decrease represents an alteration or actual loss of receptor is unknown.
Although it has been known for some time that the addition of transferrin to serum-free media provided one of the requirements for cell growth in tissue culture (6) , it was not until recently that transferrin binding sites were measured on nonhemoglobin synthesizing cells. However, other than placental cells, which require iron for delivery to the fetus (7) (8) (9) , the iron requirements of nonhemoglobin synthesizing cells appear to be relatively low (10) , and transferrin-bound iron is present in high concentrations in plasma (1 gg/ml) (10) . There is controversy, therefore, as to why these cells possess relatively large numbers of transferrin binding sites. Some studies suggest that transferrin binding sites are present in measurable quantities only on dedifferentiated or malignant cells but not on normal cells (11) , and therefore, may represent a marker for transformation. Other experiments (12, 13) indicate that both normal and malignant proliferating cells possess high densities of transferrin binding sites.
We have previously purified the transferrin receptor from human placenta (7) and, using antitransferrin receptor antibody, we have developed a radioimmunoassay for the transferrin receptor. Therefore, using both immunochemical and transferrin binding techniques, we have now measured both immunoreactive receptor protein and transferrin binding sites on reticulocytes and nucleated cells in culture. Using gradient separation of reticulocyte-rich erythrocytes, we demonstrate that the receptor is both functionally lost and immunologically either markedly altered or actually lost from the reticulocyte membrane during the process of reticulocyte maturation. Previous studies have measured transferrin binding sites on human diploid fibroblasts (12) (13) (14) and K562 cells (12) All cells were grown in 5% CO2 atmosphere in media containing 10% fetal calf serum and either MEM (fibroblasts) or RPMI 1640 (K562 cells). For studies in which fibroblasts were grown in iron-free media, MEM (which contains no measurable iron) was used with 10% "iron depleted" fetal calf serum. The fetal calf serum was made iron free by dialysis against 50 vol of 10 mM sodium acetate-NaOH, pH 5, 10 mM EDTA, and 150 mM NaCl. After dialysis for 24 h, the sera was dialyzed against 20 vol 10 mM KPO4, pH 7.5, 150 mM NaCl for 12 h, and then against 4 vol of fetal calf serum for another 24 h. Serum iron determinations (Sigma Chemical Co.) showed that iron in the dialyzed serum decreased by >95% as compared with predialysis serum.
Antibody to the purified human transferrin receptor was raised in chicken by giving three weekly injections of 100 gg of protein intradermally with all injections mixed 1:1 with complete Freund's adjuvant. At the 4th wk blood was removed from a wing vein every 48 h. The chicken antiserum was partially purified by means of ammonium sulfate precipitation and applied to an affinity column containing human transferrin-Sepharose. This latter step was used to remove the small amount of antihuman transferrin antibody in the antisera. The removal of antitransferrin antibody was measured by using a previously described radioimmunoassay for human transferrin (7) . Using this technique we found that although 2 Ml of preaffinity column antisera added to 5 ng of 125I-transferrin would specifically precipitate 50% of the radioactivity, the addition of 20 ,l of postaffinity column antisera specifically precipitated no radioactivity. This latter preparation was used in all of the studies described below in which antihuman transferrin receptor antibody was used. Partially purified control chicken serum used in the experiments was treated in the same manner as described above.
In the experiment measuring antireceptor antibody-mediated inhibition of iron incorporation into reticulocytes, erythrocytes from a patient with sickle cell anemia and a reticulocyte count of 20% were washed three times (using centrifugation) with 10 mM KPO4, pH 7.5, 150 mM NaCl. In the incubation mixture, 100 ul of the cell suspension (packed cell volume 50%) was added to 300 ul of 10 mM KPO4, pH 7.5, 150 mM NaCl, and 1 mg/ml bovine serum albumin (incubation buffer), 50 Ml of incubation buffer containing 0-10 Ml of antireceptor antibody or partially purified control serum, and 50 MAl (containing 10,000 cpm and 2 Mg transferrin) of [59Fe]transferrin in 10 mM KPO4, pH 7.5, 150 mM NaCl. Incubation was carried out at 37°C for 3 h (a time when 70% of incorporated radioactive iron comigrated with hemoglobin on Sephadex G-150). After the addition of 3 ml of ice-cold incubation buffer, the mixture was centrifuged at 500 g at 4°C. The supernatant was then removed and the pellet counted for radioactivity.
Transferrin receptor density on the surface of erythrocytes was qualitatively assayed with a double immunofluorescent antibody technique. In this assay 5 Ml of a washed (as described above) cell suspension was added to 50 50 MI of 10 mM KPO4, pH 7.5, 150 mM NaCl, and 0.1% Triton X-100 containing varying amounts of solubilized cells, 50 MI of control rabbit serum, and 20 Ml (15,000 cpm and 5 ng receptor protein) of 1251-receptor. After a 45-min incubation at 370C, 10 Ml of purified rabbit anti-chicken IgG (Cappel Laboratories, total protein 15 mg/ml) was added.
After another 45 -min incubation at 370C, tubes were immediately put in ice water and 500 Ml of cold incubation buffer containing 20% saturated ammonium sulfate (final concentration 10%) was added. The tubes were then spun at 1,000 g for 30 min at 4°C. Immediately after centrifugation the supernatant was poured off by inverting the test tubes, the top of each tube was blotted once on filter paper, and the tube, which contained a small visible precipitate, was counted for radioactivity.
For the studies using separation of reticulocytes by dextran gradients (18, 19) , the cells were reconstituted in Earle's balanced salt solution (without calcium) to a packed cell volume of -50%. After leukocytes and platelets were removed (20) from the cell suspension, the erythrocytes were applied to dextran gradients in order to separate reticulocytes. In these experiments, 750 Ml of erythrocytes were applied to the top of a discontinuous gradient that contained the following increasing concentrations of dextran (grams/ deciliter) 27, 27.8, 28.15 , and 28.5%. Gradients were spun for 1 h at 2,000 g at 22°C. Under these conditions various layers of erythrocytes were visualized, removed with a pasteur pipette, washed to remove the dextran, and reconstituted in Earle's balanced salt solution.
Binding studies were performed on cells by incubating varying concentrations (2-100 ng) of '25I-transferrin-59Fe (5,000 125I cpm/ng transferrin) with 106-107 erythrocytes or 1-3 X 105 nucleated cells in a total incubation mixture of 500 Ml of Earle's salt solution containing 1 mg/ml of ovalbumin. Incubations were carried out for 30 min at 370C (a time when specific binding to receptor was maximal for all cell types). Incubation at 37°C was chosen since previous studies measuring binding to fibroblast and K562 cells had been performed at this temperature (12, 13) . Although the results obtained under these experimental conditions are expressed in this paper (and those cited above) as binding, the data may not reflect pure surface binding since recent studies performed on whole cells incubated with 1254-transferrin at 370C indicate that transferrin is internalized (21) . After the incubation, the tubes were put in ice water, 2 ml of ice cold Earle's salt solution was added, and the tubes were centrifuged at 500 g at 4°C. The supernatant was then aspirated and the pellet counted for radioactivity. Specific binding was determined by subtracting the radioactivity in an identical sample which contained a 1,000-fold excess of nonradioactive transferrin.
Binding studies performed with '25I-OKT-9, a monoclonal antibody directed against the putative transferrin receptor (22) , were performed in the same manner as 125I-transferrin binding, except in place of radioactive transferrin, '251-OKT-9 was added (10,000 cpm/ng protein). Specific OKT-9 binding was determined by subtracting radioactivity measured in a duplicate sample containing a 100-fold excess of nonradioactive OKT-9. The specificity of binding of '25I-OKT-9 to the receptor was also assessed in some experiments by adding an excess of nonradioactive Triton-free purified placental receptor.
Studies measuring 59Fe uptake by cells in tissue culture were performed by adding [59Fe]transferrin (20,000 cpm and 5 Ag protein) to an aliquot of cells (1-4 X 106) in 5 ml of standard media for 14 h before the performance of the above assays. Cells were harvested and washed as described above and the cell pellets were counted.
[3H]Thymidine incorporation into DNA was determined (23) by adding 1 MCi of [3H]thymidine to 106 cells. After a 2.5-h incubation at 370C in 5% CO2 atmosphere, the cells were harvested, washed, precipitated with 5% TCA, and the precipitate counted for radioactivity.
RESULTS
Inhibition of functional transferrin receptor activity mediated by antireceptor antisera. To test the relationship of the antitransferrin receptor antibody to the functional transferrin receptor, we measured 59Fe uptake by reticulocytes incubated in the presence of [59Fe]transferrin. As shown in Fig. 1 Under the conditions of the radioimmunoassay, 30% of the i251-transferrin receptor precipitated in the absence of unlabeled human transferrin receptor. This value fell significantly and progressively to 5% as the amount of unlabeled, purified transferrin receptor was increased from 5 to 150 ng (Fig. 3) . Since receptors on each reticulocyte or a total of 0.4 ng of receptor/106 erythrocytes. However, six normal subjects (0.7-1.6% reticulocytes) had <0.05 ng/106 cells (Fig. 4) , or <20,000 receptor molecules/reticulocytes, and a seventh normal subject (1.4% reticulocytes) had 0.1 ng/ 106 erythrocytes (26,000 molecules/reticulocyte). In contrast, a patient with a hypoplastic bone marrow and a 1.0% reticulocyte count had 360,000 receptor molecules/reticulocyte and a patient who was hypoxic and had a 1.5% reticulocyte count had 96,000 receptor molecules/reticulocyte. Also, one of the normal subjects (1.6% reticulocytes) with initially no detectable level of receptor (<12,000 receptor molecules/reticulocyte) had a unit of blood removed and 9 d later increased her reticulocyte count to 2.5% and number of receptor molecules/reticulocyte to 29,000 (data not shown in Fig. 4) . These results suggested that these latter three subjects had more immature reticulocytes in their circulation due to premature release from the bone marrow.
Dextran gradient separation of human reticulocyte-rich erythrocytes. We decided to further study the relationship between the number of receptors on reticulocytes of varying maturity by performing dextran gradient separation of reticulocyte-rich erythrocytes. Since (19) . Using gradient separation, increasing percentages of reticulocytes were seen in the more buoyant layers using cells from a patient with autoimmune hemolytic anemia and response to folic acid therapy, who had a 44% starting reticulocyte count (Table I ). The observation that reticulocytes in the more buoyant layers were more immature (larger amounts of RNA) was further supported by the qualitative double antibody immunofluorescent method that identified a higher percentge of reticulocytes in these layers (Table I) . Assays for immunoreactive receptor resulted in higher levels of receptor in the more buoyant layers (Table I) . Calculations shown in 4: estimates from 30-500,000 transferrin binding sites/reticulocyte in studies of both human and rabbit cells). Table II shows the results of studies done after gradient separation of erythrocytes from a nonhospitalized patient with sickle cell anemia (<1% irreversibly sickle cells) and a 28% reticulocyte count. Assays for RNA using the orsinol reaction (24) (Table II) demonstrated directly that the level of immunoreactive receptor correlated with reticulocyte maturity. When results of assays for '251-transferrin binding were subjected to Scatchard analysis (25) association constants (Ka) were similar (±20%) for all layers and agreed with previous calculations (K. = 1-3 X 107/M) (5). As expected, however, the calculated amount of transferrin binding sites was higher in the more buoyant layers. Also, the decreases in transferrin binding sites in the less buoyant layers were proportional to decreases in total cellular immunoreactive receptor molecules, supporting the finding that the decrease in binding sites was due to a real loss of receptor molecules rather than changes in binding affinity or a relative shift in receptor molecules away from the cell surface. The values for transferrin binding sites were somewhat lower than the values obtained for immunoreactive receptor, suggesting that there may be an intracellular or intramembrane portion of receptor unavailable for transferrin binding.3
In vitro reticulocyte maturation. Studies designed to demonstrate the presence of an intramembrane or intracellular receptor "pool" and/or newly synthesized receptor, unavailable for binding to transferrin, were limited by the occurrence of both reticulocyte "maturation" and receptor degradation, two processes that occurred slowly at 40C, but were markedly increased at 37°C. Thus, cells from a patient with dyserythropoietic anemia, with no demonstrable he- 3 Since each receptor molecule has two subunits of identical molecular weight, the difference between receptor molecules and binding sites appears even more divergent if each receptor molecule has not one, but two transferrin binding sites. (14) that the addition of transferrin-iron to fibroblast media does not appreciably change the number of transferrin binding sites. Cells were all the same passage grown in special media for 1 wk, then were subcultured in respective media and assayed 4 d later. I Mean±SEM (three or four experiments).
S Significantly lower (P < 0.05) than other sets of cells. Not always performed in concert with binding studies.
on cells subcultured for two passages in the presence of either normal, iron-depleted, or human transferriniron-supplemented (1 mg/ml) media resulted in similar numbers of transferrin binding sites. Of interest was the fact that the Ka for the cells grown in human transferrin was always <50% of the value obtained for the other sets of cells. These results indicated that a portion of the nonradioactive human transferrin remained associated with the cells during the harvesting process and competed with 1251-human transferrin for binding. This competition in binding studies is similar to the competition described when endogenous transferrin remains bound to cells exposed to human serum (8) . The immunoassay resulted in higher calculated values for receptor as compared with binding sites (Table  III) . This difference was greater than the difference seen with the reticulocyte studies and suggested that an even larger pool of intracellular or intramembrane receptors unavailable for binding may be present in these nucleated cells. As with the binding studies, however, there was no significant difference in the number of immunologic receptor molecules in cells grown in the presence of normal, iron-depleted media, or with added human transferrin-iron. In another experiment, 30 ,M hemin added to fibroblast media for 4 d also resulted in similar levels of receptor (data not shown). These results indicated that iron availability had no signficant effect on transferrin receptor density, even while cells were subconfluent and actively growing. When compared with the results of studies performed on confluent cells, however, receptor level of cells in all forms of media was found to be inversely related to the cell density (Table III) which we hypothesized may be related to fibroblasts proliferation. At the same time that these differences were noted, confluent fibroblasts, for as long as 14 d after subculture (confluent for >1 wk), still retained significant amounts of both immunoreactive receptor and transferrin binding sites, with values similar to those obtained for 7-d fibroblasts.
Initial studies designed to measure growth rates of fibroblasts often gave variable results. We found that for consistent growth patterns, it was essential that the cells being compared be of the same passage and subcultured at an appropriate density (slightly <1 X 106 cells/75-mm T-flask for WI-38 fibroblasts). Table IV shows the results of these studies performed on WI-38 fibroblasts. Cells were subcultured at various days but all cells received fresh media 24 h before performing assays. As shown in Table IV increased [3H]thymidine uptake slightly proceeds the increase in cell growth. Also, immunoreactive transferrin receptor and transferrin binding sites are proportionally increased before the rapid growth spurt. Associated with the increase in transferrin receptor was an increase in intracellular radioactive iron in an aliquot of cells incubated with [59Fe]transferrin 14 h before immunoassays and binding studies were performed. This increase, rather than representing increased iron uptake by cells, may be a result of increased iron retention or decreased iron release (29) , but suggests that the increase in transferrin receptor is associated with increased functional activity of the receptor protein and agrees with iron incorporation studies performed on mitogen-stimulated lymphocytes (30) . Human skin fibroblasts, from two different adult subjects, gave similar results as WI-38 fibroblasts in that cells measured at 48-72 h after passage had higher levels of receptor as compared with confluent cells.
Measurement of the transferrin receptor on human leukemic (K562) cells. As opposed to fibroblasts, we found that K562 cells had a consistently predictable growth pattern (Table V) . Diluted in fresh media to a concentration of 2.5 X 105/ml, they steadily grew in a "log growth" pattern until reaching a density of _106 cells 3-4 d after culture. The cells then grew more slowly until day 7 when growth stopped at a concentration approaching 1.5 X 106 cells. At day 7 and for several days afterward, although growth had usually stopped completely, >90% of the cells remained viable. We measured '25I-OKT-9 binding to cells (Table V) Table V . These data agree with a recent report (35) that indicated that K562 cells, which avidly take up hemin from the media, continued to take up equivalent amounts of iron with or without added hemin, whereas rabbit reticulocytes decreased iron uptake when hemin was added.
DISCUSSION
Our studies have utilized a radioimmunoassay as a new tool in the measurement of transferrin receptor on reticulocytes and nonhemoglobin-synthesizing cells in tissue culture. Our results agree with a recent independent study performed by Enns et al. (36) , which used a different radioimmunoassay to measure transferrin receptor on a placental cell line in tissue culture and determine an increased amount of receptor on a reticulocyte-rich erythrocyte sample as compared with a normal erythrocyte sample. We have also performed detailed studies measuring both immunoreactive receptor levels and transferrin binding sites on a large number of samples containing reticulocytes of varying maturity and serial samples of proliferating and nonproliferating normal and malignant cells in tissues culture.
Although it has been suggested for some time (3) that the functional transferrin receptor was lost when reticulocytes matured into normal erythrocytes, little has been known concerning the rate of receptor loss and the fate of the receptor protein during the process of maturation. Recently, measurements of reticulocyte-rich samples taken from rabbits (5) and another study using gradient separation of rabbit reticulocytes (19) have both indicated that samples containing morphologically mature reticulocytes had fewer transferrin binding sites and less iron uptake as compared with immature reticulocytes. Using discontinuous dextran gradient separation of human reticulocyte-rich blood samples, we have additionally shown that not only are functional transferrin binding sites markedly increased on the more immature reticulocytes, but there is also a proportionate increase in total cellular immunoreactive receptor indicating that increased transferrin binding sites and iron uptake is due to an actual increase in receptor molecules. Conversely, the more mature reticulocytes in patients with high reticulocytes counts or the bulk of the reticulocytes found in normal blood have low or undetectable levels of both functional transferrin binding sites and immunoreactive receptor, indicating that the receptor protein is either markedly altered immunologically or entirely lost from the reticulocyte membrane to a large extent before the reticulocyte completely matures. This loss of receptor correlates with studies performed on human reticulocytes that demonstrated that only half of the reticulocytes, which in humans represented immature bone marrow reticulocytes, synthesized >90% of the hemoglobin produced (2) .
We hypothesized that utilization of the above findings might improve the clinical application of the peripheral blood reticulocyte count, which is essential in the evaluation of patients with anemia as an index of the rate of erythropoiesis. Several studies have indicated that during times of increased erythrocyte loss, a reticulocytosis is not only due to an increase in erythropoiesis, but to a variable degree also results from the stimulus for premature release of immature "stress" or "shift" reticulocytes from the bone marrow (2, 37) . Therefore, in concert with standard assays for reticulocytes an assay using immunoreactive receptor measurements to determine the proportion of immature reticulocytes would add to the utility of the reticulocyte count by providing a better index of the rate of erythropoiesis. Recently, using the fluorescent double antibody technique, we developed, in collaboration with others, an automated fluorescent detection system that selectively recognized immature reticulocytes in studies performed on rats. 4 Several recent studies have shown the existence of transferrin binding sites on nonhemoglobin-synthesizing malignant and transformed cells in both tissue culture (12, 13, 38, 39) and in vivo (11) . It has been suggested (11, 39) , therefore, that high densities of binding sites are associated only with malignancy or transformation. Other studies, however, performed mainly on mitogen-"stimulated" peripheral blood lymphocytes indicate that transferrin binding sites are markedly increased on all cells during the process of proliferation (12, 13, 22, 27, (40) (41) (42) (43) , thus supporting suggestions that more iron is required by dividing cells (44, 45) . Our studies have not only shown that both normal fibroblasts and leukemic cells in culture have increased density of immunoreactive transferrin receptor molecules slightly proceeding and during the most active state of proliferation, but additionally demonstrate, as opposed to maturing reticulocytes, that "resting," nonproliferating cells still retain about one-fifth to one-third of the immunoreactive receptor molecules. These data may indicate that the transferrin receptor is being actively synthesized, but at a reduced rate, when cells are not proliferating. Alternatively, as has been suggested (41), receptor synthesis may cease completely when cells are not proliferating and the persistence of receptors found on nonproliferating fibroblasts and leukemic cells may be entirely due to a prolonged receptor half-life.
Our studies indicate that each nondividing fibroblast retains 150,000 total immunoreactive receptor molecules and 25,000 transferrin binding sites. The latter value compares with 30,000 low density lipoprotein binding sites/cell (46) and 5,000 insulin binding sites/cell (47) previously measured on fibroblasts.
Our results show that the increase in transferrin binding sites associated with proliferation is proportionate to the increase in total cellular immunoreactive receptor molecules, indicating that increased transferrin binding on proliferating cells is not due to changes in receptor binding affinity, or to changes in receptor availability caused by a shift of intracellular receptor to the cell surface, but rather is associated with an actual increase in receptor molecules. The results of the two assays indicate that there are fewer binding sites than immunoreactive receptor molecules, 4Seligman, P. A., R. H. Allen, S. J. Kirchanski, and P. M. Natale. Automated analysis of reticulocytes using fluorescent staining with both acridine orange and an immunofluorescent technique. Submitted for publication. which suggests that there may be a large pool of intracellular or intramembrane receptor unavailable for binding. Conclusions based on the comparison of the quantitative results of the two assays may be premature, however, particularly since binding studies may vary when either different amounts of endogenous transferrin are present (7, 8) or if a variation in the rate of cellular internalization of transferrin occurs (21) .
Our studies indicate that the amount of iron available to cells has no demonstrable effect on receptor density suggesting that other factors besides receptor density are important in the regulation of iron uptake, retention, and loss by cells. For example, since free iron is toxic to cells an important regulator or intracellular iron concentration appears to be both the level of cellular ferritin and different factors responsible for the release of iron from ferritin (48, 49) . Thus in our experiments, although changes in the iron content of the media was associated with no change in transferrin receptor density, we found that cell-associated immunoreactive ferritin increased two-to threefold in cells grown in media containing human transferriniron or hemin, and decreased three-to sevenfold in cells grown in iron-depleted media.
Although nonhemoglobin-synthesizing cells may contain substantial amounts of iron bound to ferritin, measurements of total body iron indicate that these cells require very small amounts of iron at any one point in time for incorporation into iron-containing enzymes (10) . Therefore, the presence of a high density of transferrin receptors on iron-supplemented cells, and the increase in receptor density associated with proliferation appear to be more complicated processes than simply a reflection of what is presently known about the iron requirements of the cell. Transferrin receptor density may be high, however, in order to supply transferrin-bound iron to a kinetically active iron pool which cannot be supplied by ferritin iron and is a necessary requirement for unknown cellular processes including those associated with proliferation. Alternatively, high receptor density may reflect a function for transferrin other than iron transport, including delivery of other divalent cations such as zinc (50) .
Whatever the mechanism for receptor regulation, however, further elucidation of the physiologic role played by changes in transferrin receptor density should include studies performed in parallel that measure iron uptake, retention, and release by cells.
